Natural products as starting points for future anti-malarial therapies: Going back to our roots?

Malaria Journal

Volumn 10, Issue SUPPL. 1, 2011, Pages

  Wells, Timothy N C ^a  

^a Medicines for Malaria Venture   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 (9,9 DIPENTYL 9 HYDROXYNONYL) 3 HYDROXY 1,4 NAPHTHOQUINONE; ALLOCRYPTOPINE; AMODIAQUINE; ARTEMISININ; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; BERBERINE; CHLOROQUINE; CRYPTOLEPINE; CURCUMIN; FEBRIFUGINE; GEDUNIN; LAPACHOL; LAPICHOL; MEFLOQUINE; NAPHTHOQUINONE; NATURAL PRODUCT; PROTOPINE; QUININE; STRICTOSAMIDE; UNCLASSIFIED DRUG; VERNODALIN; YINGZHAOSU A;

ANTIMALARIAL ACTIVITY; BLOOD SAMPLING; CELL ASSAY; CHINESE MEDICINE; DRUG MECHANISM; DRUG POTENCY; ETHNOPHARMACOLOGY; EX VIVO STUDY; HUMAN; IN VIVO STUDY; MALARIA; MALARIA CONTROL; NONHUMAN; OBSERVATIONAL STUDY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; REVIEW;

ANTI-INFECTIVE AGENTS; ANTIMALARIALS; BIOLOGICAL PRODUCTS; DRUG DISCOVERY; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ETHNOPHARMACOLOGY; HERBAL MEDICINE; HUMANS; MALARIA; PLANTS; PLANTS, MEDICINAL; PLASMODIUM;

EID: 79952741062     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-S1-S3     Document Type: Review

References (63)

1. Artemisinin resistance in Plasmodium falciparum malaria. AM Dondorp F Nosten P Yi D Das AP Phyo J Tarning KM Lwin F Ariey W Hanpithakpong SJ Lee P Ringwald K Silamut M Imwong K Chotivanich P Lim T Herdman SS An S Yeung P Singhasivanon NP Day N Lindegardh D Socheat NJ White, N Engl J Med 2009 361 455 67 10.1056/NEJMoa0808859 19641202
2. Genomic-scale prioritization of drug targets: the TDR Targets database. F Agüero B Al-Lazikani M Aslett M Berriman FS Buckner RK Campbell S Carmona IM Carruthers AW Chan F Chen GJ Crowther MA Doyle C Hertz-Fowler AL Hopkins G McAllister S Nwaka JP Overington A Pain GV Paolini U Pieper SA Ralph A Riechers DS Roos A Sali D Shanmugam T Suzuki WC Van Voorhis CL Verlinde, Nat Rev Drug Discov 2008 7 900 7 10.1038/nrd2684 18927591
3. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. D Plouffe A Brinker C McNamara K Henson N Kato K Kuhen A Nagle F Adrin JT Matzen P Anderson TG Nam NS Gray A Chatterjee J Janes SF Yan R Trager JS Caldwell PG Schultz Y Zhou EA Winzeler, Proc Natl Acad Sci U S A 2008 105 9059 64 10.1073/pnas.0802982105 18579783
4. Thousands of chemical starting points for antimalarial lead identification. FJ Gamo LM Sanz J Vidal C de Cozar E Alvarez JL Lavandera DE Vanderwall DV Green V Kumar S Hasan JR Brown CE Peishoff LR Cardon JF Garcia-Bustos, Nature 2010 465 305 10 10.1038/nature09107 20485427
5. Chemical genetics of Plasmodium falciparum. WA Guiguemde AA Shelat D Bouck S Duffy GJ Crowther PH Davis DC Smithson M Connelly J Clark F Zhu MB Jiménez-Díaz MS Martinez EB Wilson AK Tripathi J Gut ER Sharlow I Bathurst F El Mazouni JW Fowble I Forquer PL McGinley S Castro I Angulo-Barturen S Ferrer PJ Rosenthal JL Derisi DJ Sullivan JS Lazo DS Roos MK Riscoe MA Phillips PK Rathod WC Van Voorhis VM Avery RK Guy, Nature 2010 465 311 5 10.1038/nature09099 20485428
6. Microbiology. Is the tide turning for new malaria medicines? TNC Wells, Science 2010 329 1153 4 10.1126/science.1194923 20813940
7. Spiroindolones, a new and potent chemotype for 1 the treatment of malaria. M Rottmann C McNamara BKS Yeung MCS Lee B Zou B Russell P Seitz D Pluoffe NV Dharia J Tan SB Cohen KR Spencer GE Gonzalez-Paez SB Lakshminarayana A Goh R Suwanarusk T Jegla EK Schmitt HP Beck R Brun F Nosten L Renia V Dartois TH Keller DA Fiddock EA Winzeler TT Diagana, Science 2010 329 1175 80 10.1126/science.1193225 20813948
8. Antimalarial compounds isolated from plants used in traditional medicine. J Bero M Frédérich J Quetin-Leclerq, J Pharm Pharmacol 2009 61 1401 1433 10.1211/jpp.61.11.0001 19903367
9. Molecular Complexity and its impact on the probability of finding leads for drug discovery. MM Hann AR Leach G Harper, J Chem Inf Comput Sci 2001 41 856 864 11410068
10. Ligand Binding Efficiency: Trends Physical Basis and Implications. CH Reynolds BA Tounge SD Bembenek, J Med Chem 2008 51 2432 2438 10.1021/jm701255b 18380424 (Pubitemid 351628504)
11. Novartis natural products paper in this journal.
12. Atovaquone - a novel broad-spectrum anti-infective drug. AT Hudson, Parasitol Today 1993 9 66 8 10.1016/0169-4758(93)90040-M 15463712 (Pubitemid 23038653)
13. Identification of an antimalarial synthetic trioxolane drug development candidate. JL Vennerstrom S Arbe-Barnes R Brun SA Charman FC Chiu J Chollet Y Dong A Dorn D Hunziker H Matile K McIntosh M Padmanilayam J Santo Tomas C Scheurer B Scorneaux Y Tang H Urwyler S Wittlin WN Charman, Nature 2004 430 900 4 10.1038/nature02779 15318224 (Pubitemid 39119218)
14. New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays. JB Baell GA Holloway, J Med Chem 2010 53 2719 2740 10.1021/jm901137j 20131845
15. Herb and supplement use in the US adult population. J Kennedy, Clin Ther 2005 27 1847 1858 10.1016/j.clinthera.2005.11.004 16368456 (Pubitemid 41815236)
16. Guideline on non-clincal documentation for herbal medicinal products in application for marketing authorisation. European Medicines Agency, 2006 http://www.ema.europa.eu/pdfs/human/hmpc/3211605en.pdf
17. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. JL Vanherweghem M Depierreux C Tielemans D Abramowicz M Dratwa M Jadoul C Richard D Vandervelde D Verbeelen R Vanhaelen-Fastre M Vanhaelen, Lancet 1993 341 387 391 10.1016/0140-6736(93)92984-2 8094166 (Pubitemid 23048140)
18. Late onset of bladder urothelial carcinoma after kidney transplantation for endstage aristolochic acid nephropathy: a case series with 15-year follow-up. A Lemy KM Wissing S Rorive A Zlotta T Roumeguere MC Muniz Martinez C Decaestecker I Salmon D Abramowicz JL Vanherweghem J Nortier, Am J Kidney Dis 2008 51 471 477 10.1053/j.ajkd.2007.11.015 18295063 (Pubitemid 351273477)
19. The African Network for Drugs and Diagnostics Innovation. T Mboya-Okeyo RG Ridley S Nwaka ANDI Task Force, Lancet 2009 373 1507 8 10.1016/S0140-6736(09) 60838-2 19410700
20. S Nwaka
21. General guidelines for methodologies on research and evaluation of traditional medicine. WHO, 2000 http://apps.who.int/medicinedocs/en/d/ Jwhozip42e/
22. Herbal remedies for malaria. DA Warrell, Trop Doct 1997 27 suppl 1 5 6 9204715
23. Ethnopharmacology, sustainable development and cooperation: the importance of gathering clinical data during field surveys. B Graz J Falquet E Elisabetsky, J Ethnopharmacol 2010 130 635 8 10.1016/j.jep.2010.04.044 20466053
24. Argemone mexicana decoction for the treatment of uncomplicated falciparum malaria. ML Willcox B Graz J Falquet O Sidibe M Forster D Diallo, Trans R Soc Trop Med Hyg 2007 101 1190 1198 10.1016/j.trstmh.2007.05.017 17920092 (Pubitemid 350028620)
25. From Changshan to a new antimalarial drug. SH Lei, Social Studies of Science 1999 29 323 58 10.1177/030631299029003001
26. Analysis of the adult human plasma metabolome. KA Lawton A Berger M Mitchell KE Milgram AM Evans L Guo RW Hanson SC Kalhan JA Ryals MV Milburn, Pharmacogenomics 2008 9 383 397 10.2217/14622416.9.4.383 18384253 (Pubitemid 351803924)
27. Xenobiotic metabolism: a view through the metabolometer. AD Patterson FJ Gonzalez JR Idle, Chem Res Toxicol 2010 23 851 860 10.1021/tx100020p 20232918
28. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. TN Wells JN Burrows JK Baird, Trends Parasitol 2010 26 145 51 10.1016/j.pt.2009.12.005 20133198
29. Antimalarial activity and toxicity evaluation of a quantified Nauclea pobeguinii extract. K Mesia RK Cimanga L Dhooghe P Cos S Apers J Totte G Tona L Pieters AJ Vlietinck L Maes, J Ethnopharmacol 2010 131 10 16 10.1016/j.jep.2010.05.008 20470876
30. Antimalarial drug discovery: efficacy models for compound screening. DA Fidock PJ Rosenthal SL Croft R Brun S Nwaka, Nat Rev Drug Discov 2004 3 509 20 10.1038/nrd1416 15173840 (Pubitemid 38807533)
31. Improved murine model of malaria using Plasmodium falciparum competent strains and non-myodepleted NOD-scid IL2-Rgamma null mice engrafted with human erythrocysts. MB Jiménez-Díaz T Mulet S Viera V Gámez H Garuti J Ib̃ez A Alvarez-Doval LD Shultz A Martínez D Gargallo-Viola I Angulo-Barturen, Antimicrob Agents Chemother 2009 53 4533 6 10.1128/AAC.00519-09 19596869
32. Prolonged engraftment of human hepatocytes in mice transgenic for the deleted form of human hepatocyte growth factor. A Krishnan K Viker H Rietema M Telgenkamp B Knudsen M Charlton, Hepatol Res 2007 37 854 862 10.1111/j.1872-034X.2007.00139.x 17573952 (Pubitemid 47308228)
33. Activity of a combination of three cinchona bark alkaloids against Plasmodium falciparum in vitro. P Druihle O Brandicourt T Chongsuphajaisiddhi J Berth, Antimicrob Agents Chemother 1988 32 250 254 3284455 (Pubitemid 18061384)
34. Pharmacokinetics of quinine, quinidine and cinchonine when given as combination. J Karbwang D Bunnag T Harinasuta S Chittamas J Berth P Druilhe, Southeast Asian J Trop Med Public Health 1992 23 773 776 1298088 (Pubitemid 23121542)
35. Potentiation of the antimalarial activity of Qinghaosu by methoxylated flavones. BC Elford MF Roberts JD Phillipson RJM Wilson, Trans R Soc Trop Med Hyg 1987 81 434 436 10.1016/0035-9203(87)90161-1 3318019
36. Heyerik A potential synergism with artemsinin against malaria and cancer. JFS Ferreira DL Luthria T Sasaki, Molecules 2010 15 3135 3170 10.3390/molecules15053135 20657468
37. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. NJ White W Pongtavornpinyo RJ Maude S Saralamba R Aguas K Stepniewska SJ Lee AM Dondorp LJ White NP Day, Malar J 2009 8 253 10.1186/1475-2875-8-253 19906307
38. Drug development from marine natural products. TF Molinski DS Salisay SL Lievens JP Saludes, Nature Reviews Drug Discovery 2009 8 69 85 10.1038/nrd2487 19096380
39. Quinine's Predecessor: Francesco Torti and the Early History of Cinchona,. S Jarcho, Saul Johns Hopkins University Press ISBN0-8018-4466-5 1993
40. Guidelines for the treatment of malaria World Health Organisation. second 2010 http://whqlibdoc.who.int/publications/2010/9789241547925-eng.pdf
41. In vitro activity of natural and synthetic naphthoquinones against erythrocytic stages of Plasmodium falciparum. LH Carvalho EM Rocha DS Raslan AB Oliveira AU Krettli, Braz J Med Biol Res 1988 21 485 7 3067810
42. Naphthoquinone Antimalarials. XXIV. A New Synthesis of Lapinone. LF Fieser G Fawaz, J Am Chem Soc 1950 72 996 1000 10.1021/ja01158a091
43. Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria. MS Mueller N Runyambo I Wagner S Borrmann K Dietz L Heide, Trans R Soc Trop Med Hyg 2004 98 318 21 10.1016/j.trstmh.2003.09.001 15109558 (Pubitemid 38950411)
44. Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood). K Räth K Taxis G Walz CH Gleiter SM Li L Heide, Am J Trop Med Hyg 2004 70 128 32 14993622 (Pubitemid 38200515)
45. Herbal Artemisiae annuae tea preparation compared to sulfadoxinepyrimethaminein the treatment of uncomplicated falciparum malaria in adults: a randomized double-blind clinical trial. CH Blanke GB Naisabha MB Balema GM Mbarku L Heide MS Mueller, Trop Doct 2008 38 113 116 10.1258/td.2007.060184 18453510
46. Efficacy of Ro 42-1611 (arteflene) in the treatment of patients with mild malaria: a clinical trial in Cameroon. R Somo-Moyou ML Mittelholzer F Sorenson L Haller D Stürchler, Trop Med Parasitol 1994 45 288 291 7899806 (Pubitemid 24312043)
47. The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites. JN Lisgarten M Coll J Portugal CW Wright J Aymami, Nat Struct Biol 2001 9 57 60 10.1038/nsb729 (Pubitemid 34049181)
48. Antimalarial activity of crytolepine and some other anhydronium bases. CW Wright JD Phillipson SO Awe GC Kirby DC Warhurst J Quetin-Leclerq L Angenot, Phytother Res 1996 10 361 363 10.1002/(SICI)1099-1573(199606)10:4<361::AID- PTR845>3.0.CO;2-N (Pubitemid 26195883)
49. Assessment of the Short-Term Safety and Tolerability of a Quantified 80 % Ethanol Extract from the Stem Bark of Nauclea pobeguinii (PR 259 CT1) in Healthy Volunteers: A Clinical Phase I Study. K Mesia K Cimanga L Tona MM Mampunza N Ntamabyaliro T Muanda T Muyembe J Totté T Mets L Pieters A Vlietinck, Planta Med 2010 20665369
50. Clinical trial of Pr259ct1 versus artesunate-amodiaquine (AS-AQ) in patients with uncomplicated malaria in the Democratic Republic of Congo (DRC). GL Tona, 2009 http://www.edctpforum2009.org/fileadmin/documents/forum09/ Forum2009-programme-book.pdf 19951738
51. Argemone mexicana decoction for the treatment of uncomplicated falciparum malaria. ML Willcox B Graz J Falquet O Sidibe M Forster D Diallo, Trans R Soc Trop Med Hyg 2007 101 1190 1198 10.1016/j.trstmh.2007.05.017 17920092 (Pubitemid 350028620)
52. Argemone mexicana decoction versus artesunate-amodiaquine for the management of malaria in Mali: policy and public-health implication. B Graz ML Milcox C Diakite J Falquet F Dackuo S Giani D Siallo, Trans R Soc Trop Med Hyg 2010 104 33 41 10.1016/j.trstmh.2009.07.005 19733875
53. The Analgesic and Antiplasmodial Activities and Toxicology of Vernonia amygdalina. AA Njan B Adzu AG Agaba D Byarugaba S Llera-Diau DR Bangsberg, J Med Food 2008 11 574 581 10.1089/jmf.2007.0511 18800909
54. A clinical trial of Veronia amygdalina in the treatment of uncomplicated malaria. S Challand M Willcox, J Altern Complement Med 2009 15 1231 1237 10.1089/acm.2009.0098 19922255
55. Ch'ang Shan, a Chinese Antimalarial Herb Science. CS Jang FY Fu CY Wang KC Huang G Lu TC Chou, Science 1946 103 59 10.1126/science.103.2663.59-b
56. Synthesis and biological evaluation of febrifugine analogues as potential antimalarial agents. S Zhu Q Zhang C Gudise L Wei E Smith Y Zeng, Bioorg Med Chem 2009 17 4496 4502 10.1016/j.bmc.2009.05.011 19467876
57. Gene expression signature based chemical genomic prediction identifies a novel class of Hsp90 pathway modifiers. H Hieronymus J Lamb KN Ross XP Peng C Clement A Rodina M Nieto J Du K Stegmaier SM Raj KN Maloney J Clardy WC Hahn G Chiosis TR Golub, Cancer Cell 2006 10 321 330 10.1016/j.ccr.2006.09.005 17010675 (Pubitemid 44512193)
58. Neem (Azadirachta indica) in Traditional Medicinal Plants and Malaria. M Wilcox J Chamberlain, Willcox M Bodeker G Rasoanaivo CRC, 2004 91 115
59. Fractionated neem leaf extract is safe and increases CD4+ cell levels in HIV/AIDS patients. AU Mbah IJ Udeinya EN Shu CP Chijioke T Nubila F Udeinya A Muobuike A Mmuobieri MS Obioma, Am. J. Ther 2007 14 369 374 10.1097/MJT. 0b013e3180a72199 17667213 (Pubitemid 47220848)
60. Antimalarial activity of tropical meliaceae extracts and gedunin derivatives. S Mackinnon T Durst JT Arnason C Angerhofer J Pezzuto PE Sanchez-Winday LJ Poveda M Gbeassor, J Nat Prod 1997 60 336 341 10.1021/np9605394 9134742 (Pubitemid 27184907)
61. Antimalarial activities of gedunin and 7-methoxygedunin and synergistic activities with dillaiol. S Omar K Godard A Ingham H Hussain V Wongpanich J Pezzuto T Durst C Eklu M Gbeassor P Sanchez-Vindas L Poveda BJR Philogene JT Arnason, Ann Appl Biol 2003 143 135 141 10.1111/j.1744-7348.2003.tb00279.x (Pubitemid 37215944)
62. Comparative efficacy of Ayush-64 vs chloroquine in vivax malaria. N Valecha CU Devi H Joshi VK Shahi S Lal, Current Science 2000 78 1120 1122
63. Traditional herbal medicines for malaria. ML Willcox G Bodeker, British Medical Journal 2004 329 1156 1159 10.1136/bmj.329.7475.1156 15539672 (Pubitemid 39524776)